What is the life expectancy of an adult patient with impaired renal function, as indicated by a glomerular filtration rate (GFR) of 23, and presenting with edema, who refuses to see a nephrologist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prognosis for GFR 23 with Refusal of Nephrology Care

This patient with Stage 4 CKD (GFR 23) and edema who refuses nephrology care faces significantly increased mortality risk, with life expectancy highly variable but potentially measured in months to a few years depending on underlying cause, rate of progression, and cardiovascular comorbidities—though without specialist intervention, outcomes will be substantially worse than with appropriate nephrology management.

Understanding the Clinical Severity

  • A GFR of 23 mL/min/1.73 m² represents Stage 4 CKD (GFR 15-29), which is severe kidney dysfunction requiring immediate nephrology referral according to established guidelines 1.

  • The presence of edema indicates volume overload and suggests the kidneys are failing to regulate fluid balance, which is a sign of advancing kidney dysfunction and potential progression toward Stage 5 (kidney failure) 1.

  • Late referral to nephrology is directly associated with increased mortality after dialysis initiation, and this patient is refusing even timely referral 1.

Prognostic Factors Without Nephrology Care

Immediate Risks

  • Patients with GFR <30 mL/min/1.73 m² should begin preparation for kidney replacement therapy, as uremic symptoms typically develop when GFR declines below 15 mL/min/1.73 m² 1.

  • Without nephrology management, complications of Stage 4 CKD will progress unchecked, including anemia, bone disease, metabolic acidosis, malnutrition, neuropathy, and cardiovascular disease 1.

  • CKD patients are at extremely high risk for cardiovascular events, which is the leading cause of death—not kidney failure itself 2, 3.

Life Expectancy Considerations

  • The vast majority of patients with Stage 3 CKD die from cardiovascular causes rather than progressing to end-stage renal disease (ESRD) 1.

  • With Stage 4 CKD (GFR 23), the risk of both cardiovascular death and progression to ESRD requiring dialysis is substantially elevated 2, 3.

  • Progression rate depends heavily on the underlying cause (diabetes, hypertension, glomerulonephritis), presence and severity of proteinuria, blood pressure control, and cardiovascular comorbidities 2, 4.

  • Without intervention, progression from GFR 23 to kidney failure (GFR <15) requiring dialysis could occur within 6 months to 2-3 years, though some patients may stabilize for longer periods 4.

Critical Interventions That Are Being Missed

What Nephrology Would Provide

  • Preparation for kidney replacement therapy should begin at Stage 4 CKD to improve outcomes and reduce mortality 1.

  • Management of CKD complications (anemia, bone disease, metabolic acidosis) that significantly impact quality of life and mortality 1, 5.

  • Aggressive cardiovascular risk reduction, which is the primary determinant of survival in this population 1, 6.

What Primary Care Must Do

  • Blood pressure control is absolutely critical—target <130/80 mmHg with renin-angiotensin-aldosterone system (RAAS) inhibitors 2, 3.

  • Initiate or optimize SGLT2 inhibitors, which reduce cardiovascular and kidney disease progression risk 3.

  • Statin therapy for cardiovascular risk reduction 3.

  • Assess and treat proteinuria, as higher levels predict faster progression to ESRD 1, 2.

  • Manage volume overload with diuretics to address the edema 1.

  • Screen for and treat complications: anemia (hemoglobin), bone disease (calcium, phosphorus, PTH), metabolic acidosis (bicarbonate) 1, 5.

The Refusal Problem

Immediate Approach

  • Document the patient's refusal of nephrology care and the explained risks, including increased mortality and preventable complications 7, 6.

  • Explore barriers to nephrology referral: transportation, cost, fear, misunderstanding of severity, or nihilism about treatment 7.

  • Emphasize that nephrology care is not just about dialysis—it's about preventing complications, improving quality of life, and extending survival 7, 6.

Harm Reduction Strategy

  • If the patient absolutely refuses nephrology care, primary care must implement the core interventions: blood pressure control with RAAS inhibitors, SGLT2 inhibitors, statins, management of volume overload, and monitoring for complications 3, 5.

  • Reassess willingness for nephrology referral at every visit, as patient perspectives may change as symptoms worsen 7.

  • Consider involving family members or social work to address barriers to specialist care 6.

Realistic Prognosis

Without nephrology care and aggressive management, this patient faces:

  • High risk of cardiovascular death within 1-3 years 1, 2.

  • Progression to kidney failure requiring emergency dialysis initiation within months to 2 years, which carries much higher mortality than planned dialysis initiation 1.

  • Progressive decline in quality of life from untreated uremic symptoms, anemia, bone disease, and volume overload 1, 6.

  • If underlying cause is rapidly progressive (such as uncontrolled diabetes or glomerulonephritis), progression to ESRD could occur within 6-12 months 4.

The refusal of nephrology care eliminates the opportunity for predialysis education, timely access creation, and preventive interventions that significantly reduce initial dialysis morbidity and mortality 7, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Approach to Chronic Kidney Disease with Normal Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Chronic kidney disease in primary care.

Journal of the American Board of Family Medicine : JABFM, 2010

Research

Introduction: chronic kidney disease: a burgeoning health epidemic.

Journal of managed care pharmacy : JMCP, 2007

Related Questions

What is the best standard for CKD (Chronic Kidney Disease) patients to follow their doctor's orders?
What is the appropriate management plan for a patient with advanced chronic kidney disease, presenting with symptoms such as generalized swelling, vomiting, dizziness, fatigue, shortness of breath, decreased urine output, and back pain, with laboratory results showing impaired renal function, hyperkalemia, hyponatremia, hypocalcemia, and significant proteinuria?
What treatment options are available for a 28-year-old with impaired renal function?
What is the recommended follow-up care for someone with normal kidney function?
What are the recommended diet and medical care for a 60-year-old obese male with diabetes (Diabetes Mellitus), hypertension (High Blood Pressure), and Chronic Kidney Disease (CKD) with impaired renal function?
What is a comprehensive psych assessment script for a patient with a mood disorder, considering their demographic information, medical and psychiatric history, and current symptoms?
What is the recommended diet for an outpatient with diverticulitis?
What is the preferred dose of estradiol (E2) patch, measured in micrograms (mcg), for a perimenopausal woman experiencing symptoms?
What is the best course of action for a patient with Restless Legs Syndrome (RLS) who is currently on methadone (opioid analgesic) 5mg and still experiencing symptoms?
What are the considerations for combining lisinopril (Angiotensin-Converting Enzyme Inhibitor) with prednisone (corticosteroid) and Rinvoq (upadacitinib) in an adult patient with a history of autoimmune disease, specifically rheumatoid arthritis and hypertension, with potential cardiovascular comorbidities?
What is the diagnosis and treatment for a 21-year-old (yo) female with 2 days of pelvic pain, dyspareunia, vaginal discharge, and cervical motion tenderness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.